Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Govt agencies, non-govt organisations collaborate on non-animal methodologies workshop
Biotechnology Industry Research Assistance Council, Office of Principal Scientific Advisor and Humane Society International/India…
Power Gummies raises ₹10 cr, aims to expand product range
The funding would be used to launch a zero-sugar range, upgrade compositions to make the brand sugar-free and diversify into…
SKAN Research Trust secures two govt recognitions
The recognitions include Research Association for Scientific Research under Section 35(1)(ii) of the Income-tax Act, 1961 and…
Asahi Kasei Pharma enters into exclusive license agreement for anti-CX3CR1 Antibody
The anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell…
Gerresheimer completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma…
The acquisition creates a new moulded glass unit with a diversified product portfolio for the pharmaceutical, cosmetics, food and…
Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in…
Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
AIPAC launches first training programme for Pharma MSMEs in Indore
The collaborative programme seeks to bridge the knowledge gap for MSMEs in the pharmaceutical industry
Amgen India appoints Naveen Gullapalli as Managing Director
Gullapalli will lead the Amgen India Technology and Innovation site in Hyderabad
Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030
GlobalData’s latest report reveals that market growth will primarily be driven by the uptake of new monoclonal antibodies (mAbs),…
Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in…
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5 per cent;…